Molecular Characterization of Acute Cellular Rejection Occurring During Intentional Immunosuppression Withdrawal in Liver Transplantation-Reference-Cited by-同舟云学术

Molecular Characterization of Acute Cellular Rejection Occurring During Intentional Immunosuppression Withdrawal in Liver Transplantation

Published:2015-10-30 Issue:2 Volume:16 Page:484-496
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Bonaccorsi-Riani E.¹,Pennycuick A.¹,Londoño M.-C.²,Lozano J.-J.³,Benítez C.²,Sawitzki B.⁴,Martínez-Picola M.²,Bohne F.⁵,Martínez-Llordella M.¹,Miquel R.¹,Rimola A.²,Sánchez-Fueyo A.¹²

Affiliation:

1. Department of Liver Studies, Division of Transplantation Immunology and Mucosal Biology, Medical Research Council Centre for Transplantation, Faculty of Life Sciences and Medicine; King's College London University, King's College Hospital; Denmark Hill London UK

2. Liver Unit, Hospital Clinic Barcelona, Institut d’ Investigacions Biomedicas August Pi i Sunyer (IDIBAPS), Networked Biomedical Research Centre of Hepatic and Digestive Diseases (CIBERehd); University of Barcelona; Barcelona Spain

3. Bioinformatics Platform; CIBEREHD Barcelona Spain

4. AG Transplantationstoleranz, Charite Universitätsmedizin; Institut für Med. Immunologie; Berlin Germany

5. Institute of Virology; Technische Universität München/Helmholtz Zentrum München; Munich Germany

Funder

Roche Organ Transplant Research Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference33 articles.

1. 2011

2. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: The 2000-2003 phase II prospective randomized trial;Asrani;Am J Transplant,2014